Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 6/20 | 0.54 |
| ▸ | KDM5A | P29375 | 4/20 | 0.54 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.54 |
| ▸ | KDM5C | P41229 | 1/20 | 0.51 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.51 |
| ▸ | KDM4A | O75164 | 2/20 | 0.50 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.50 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.50 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.50 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.48 |
| ▸ | PPARG | P37231 | 7/20 | 0.48 |
| ▸ | PPARD | Q03181 | 7/20 | 0.48 |
| ▸ | PPARA | Q07869 | 7/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | TLR2 | O60603 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8093289 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL5984529 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL28942179 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL448290 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL16895244 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL41611 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL5984033 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL10610457 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL1272817 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B | |
| SCHEMBL27082196 | 1.00 | KDM4C (0.54) | KDM4CKDM5APHF8KDM5CKDM5B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2317 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4716693-A2 | PHARMACEUTICAL COMPOSITIONS FOR ANTIBODIES AND MAKING AND USING THE SAME | INVETX, INC. (US) | 2026-04-01 | — | — | EP | claimed |
| EP-4021643-B1 | A COLLECTOR COMPOSITION FOR THE LITHIUM ORE OR MAGNESIUM ORE FLOTATION | BASF SE (DE) | 2025-12-03 | — | — | EP | claimed |
| US-12478982-B2 | Collector composition | BASF SE (DE) | 2025-11-25 | — | — | US | claimed |
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4642484-A1 | TARGETED TREATMENT OF PROSTATE CANCERS AND OTHER TUMORS BY AN ANTIBODY-DRUG CONJUGATE | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| WO-2024243322-A9 | PHARMACEUTICAL COMPOSITIONS FOR ANTIBODIES AND MAKING AND USING THE SAME | INVETX, INC. (US) | 2025-03-27 | — | — | WO | claimed |
| US-20250073319-A1 | LYOPHILIZED ENPP1 POLYPEPTIDE FORMULATIONS AND USES THEREOF | BIOMARIN PHARMACEUTICAL INC. | 2025-03-06 | — | — | US | claimed |
| US-20240398825-A1 | MELOXICAM COMPOSITION, PHARMACEUTICAL PREPARATION, AND PREPARATION METHOD AND USE THEREOF | NANJING DELOVA BIOTECH CO., LTD. (CN) | 2024-12-05 | — | — | US | claimed |
| US-20240392009-A1 | PHARMACEUTICAL COMPOSITIONS FOR ANTIBODIES AND MAKING AND USING THE SAME | INVETX INC (US) | 2024-11-28 | — | — | US | claimed |
| WO-2024240173-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2024-11-28 | — | — | WO | claimed |
| US-20180000932-A1 | FORMULATION OF AGLYCOSYLATED THERAPEUTIC ANTIBODIES | NOVELMED THERAPEUTICS INC (US) | 2018-01-04 | — | — | US | claimed |
| EP-3240571-A1 | FORMULATION OF AGLYCOSYLATED THERAPEUTIC ANTIBODIES | NovelMed Therapeutics, Inc. (US) | 2017-11-08 | — | — | EP | claimed |
| EP-2585105-B1 | TREATMENT OF SANFILIPPO SYNDROME TYPE B | SHIRE HUMAN GENETIC THERAPIES (US) | 2017-08-09 | — | — | EP | claimed |
| CN-106726670-A | A kind of skin protection cosmetics comprising N acyl aminos hydrochlorate/plant peptide combinations and preparation method thereof | 长沙普济生物科技股份有限公司 | 2017-05-31 | — | — | CN | claimed |
| CN-106491380-A | Special N acylamino acids anion surfactant type mildy wash/cream of a kind of face cleaning instrument and preparation method thereof | 长沙普济生物科技股份有限公司 | 2017-03-15 | — | — | CN | claimed |
| US-20160263223-A1 | STABLE SUBCUTANEOUS PROTEIN FORMULATIONS AND USES THEREOF | BRISTOL MYERS SQUIBB CO (US) | 2016-09-15 | — | — | US | claimed |
| EP-3048899-A2 | ON-COLUMN VIRAL INACTIVATION METHODS | Biogen MA Inc. (US) | 2016-08-03 | — | — | EP | claimed |
| WO-2016109822-A1 | FORMULATION OF AGLYCOSYLATED THERAPEUTIC ANTIBODIES | NOVELMED THERAPEUTICS, INC. (US) | 2016-07-07 | — | — | WO | claimed |
| US-9309316-B2 | Stable subcutaneous protein formulations and uses thereof | BRISTOL-MYERS SQUIBB COMPANY (US) | 2016-04-12 | — | — | US | claimed |
| WO-2015048330-A2 | ON-COLUMN VIRAL INACTIVATION METHODS | BIOGEN IDEC MA INC. (US) | 2015-04-02 | — | — | WO | claimed |